Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Bioxyne Ltd

BXN.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Biotechnology & Medical Research ·

Australia Micro Cap Analyst: N/A

Last Close

$0.66

▼ -1.59%

Market Cap $153.55M · Vol 120.61K

Key Metrics

P/E Ratio

23.83

FWD: N/A

Market Cap

$153.55M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

70.00

Momentum

Beta

1.02

vs Market

52W High

$0.79

13.79% below

52W Low

$0.24

209.39% above

Volume

120.61K

Avg 157.18K

P/B

7.15

Price-to-book

ROE

N/A

Return on equity

Free Float

43.74%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Bioxyne Ltd (BXN.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BXN.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-0.53%

+10.71%

+36.76%

+93.75%

YTD

+121.43%

+69.09%

+765.70%

+190.63%

Financials & Valuation

TTM · Annual

Total Revenue	$19.27M
Net Income	$3.22M
Revenue Growth (YoY)	+149.71%
Gross Margin	36.62%
Operating Margin	16.70%
Net Profit Margin	16.73%
ROE	N/A
ROA · ROIC	37.31% · 55.55%

P/E Ratio	23.83
Forward P/E (FY1)	N/A
PEG Ratio	0.13
P/S	3.01
P/B	7.15
P/FCF	20.95
EPS Growth	N/A
Outstanding Shares	230.30M

Technical Indicators

50-Day SMA	$0.65
200-Day SMA	$0.45
RSI (14)	70.00
Beta	1.02
52-Week High	$0.79
52-Week Low	$0.24

Volume Today	120.61K
Avg Daily Volume (30D)	157.18K
Relative Volume	0.77x
Volatility (10D)	25.64
Volatility (30D)	40.47
Free Float	43.74%

Analyst Consensus

N/A

Current Price $0.66

Mean Target N/A

52W Low$0.24 52W High$0.79

Current

Target

$0.24 $0.79

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG001SGDXS4

ISINAU000000BXN6

CountryAustralia

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LONN.S Lonza Group AG -0.74% RVMD Revolution Medicines Inc +1.01% ONC BeOne Medicines AG -0.66% 068270.KS Celltrion Inc +0.88% ABVX Abivax SA +1.04%

Company Profile

Bioxyne Limited is an Australia-based international consumer health and pharmaceutical company. The Company is focused on health and wellness products, psychotropic and investigational medicines. The Company operates through three segments: Wholesale PCC/USA, Consumer Health Products UK/ EU/JPN, and Pharmaceuticals AUS. Its subsidiary, Breathe Life Sciences (BLS) manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabidiol (CBD), cannabis extracts, vitamins, manuka honey, skin care products and mushroom complexes. BLS operates in Australia, the United Kingdom, Japan, and Europe with four accredited manufacturing facilities across four countries Japan, Australia, the United Kingdom, and Czechia. The Company direct sales arm and has developed a range of functional food products containing ingredients sourced exclusively from New Zealand and sold in Asia.